Global Opioid-induced Constipation Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Opioid-induced Constipation will have significant change from previous year. According to our (LP Information) latest study, the global Opioid-induced Constipation market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Opioid-induced Constipation market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Opioid-induced Constipation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Opioid-induced Constipation market, reaching US$ million by the year 2028. As for the Europe Opioid-induced Constipation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Opioid-induced Constipation players cover AstraZeneca, Takeda Pharmaceutical, Bausch Health, and Abbott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid-induced Constipation market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Opioid-induced Constipation will have significant change from previous year. According to our (LP Information) latest study, the global Opioid-induced Constipation market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Opioid-induced Constipation market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Opioid-induced Constipation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Opioid-induced Constipation market, reaching US$ million by the year 2028. As for the Europe Opioid-induced Constipation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Opioid-induced Constipation players cover AstraZeneca, Takeda Pharmaceutical, Bausch Health, and Abbott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid-induced Constipation market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Solid
- Liquid
- Drugstore
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Takeda Pharmaceutical
- Bausch Health
- Abbott
- Bayer
- Boehringer Ingelheim
- C.B. Fleet
- Cosmo Pharmaceuticals
- Daewoong
- Daiichi Sankyo
- GlaxoSmithKline
- Ironwood Pharmaceuticals
- Johnson and Johnson
- Merck
- Mundipharma
- Nektar Therapeutics
- Pfizer
- Progenics Pharmaceuticals
- Shionogi
- SLA Pharma
- Sucampo
- Synergy Pharmaceuticals
- Theravance
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid-induced Constipation Market Size 2017-2028
2.1.2 Opioid-induced Constipation Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Opioid-induced Constipation Segment by Type
2.2.1 Solid
2.2.2 Liquid
2.3 Opioid-induced Constipation Market Size by Type
2.3.1 Opioid-induced Constipation Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
2.4 Opioid-induced Constipation Segment by Application
2.4.1 Drugstore
2.4.2 Hospital
2.4.3 Others
2.5 Opioid-induced Constipation Market Size by Application
2.5.1 Opioid-induced Constipation Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
3 OPIOID-INDUCED CONSTIPATION MARKET SIZE BY PLAYER
3.1 Opioid-induced Constipation Market Size Market Share by Players
3.1.1 Global Opioid-induced Constipation Revenue by Players (2020-2022)
3.1.2 Global Opioid-induced Constipation Revenue Market Share by Players (2020-2022)
3.2 Global Opioid-induced Constipation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OPIOID-INDUCED CONSTIPATION BY REGIONS
4.1 Opioid-induced Constipation Market Size by Regions (2017-2022)
4.2 Americas Opioid-induced Constipation Market Size Growth (2017-2022)
4.3 APAC Opioid-induced Constipation Market Size Growth (2017-2022)
4.4 Europe Opioid-induced Constipation Market Size Growth (2017-2022)
4.5 Middle East & Africa Opioid-induced Constipation Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Opioid-induced Constipation Market Size by Country (2017-2022)
5.2 Americas Opioid-induced Constipation Market Size by Type (2017-2022)
5.3 Americas Opioid-induced Constipation Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid-induced Constipation Market Size by Region (2017-2022)
6.2 APAC Opioid-induced Constipation Market Size by Type (2017-2022)
6.3 APAC Opioid-induced Constipation Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Opioid-induced Constipation by Country (2017-2022)
7.2 Europe Opioid-induced Constipation Market Size by Type (2017-2022)
7.3 Europe Opioid-induced Constipation Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid-induced Constipation by Region (2017-2022)
8.2 Middle East & Africa Opioid-induced Constipation Market Size by Type (2017-2022)
8.3 Middle East & Africa Opioid-induced Constipation Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET FORECAST
10.1 Global Opioid-induced Constipation Forecast by Regions (2023-2028)
10.1.1 Global Opioid-induced Constipation Forecast by Regions (2023-2028)
10.1.2 Americas Opioid-induced Constipation Forecast
10.1.3 APAC Opioid-induced Constipation Forecast
10.1.4 Europe Opioid-induced Constipation Forecast
10.1.5 Middle East & Africa Opioid-induced Constipation Forecast
10.2 Americas Opioid-induced Constipation Forecast by Country (2023-2028)
10.2.1 United States Opioid-induced Constipation Market Forecast
10.2.2 Canada Opioid-induced Constipation Market Forecast
10.2.3 Mexico Opioid-induced Constipation Market Forecast
10.2.4 Brazil Opioid-induced Constipation Market Forecast
10.3 APAC Opioid-induced Constipation Forecast by Region (2023-2028)
10.3.1 China Opioid-induced Constipation Market Forecast
10.3.2 Japan Opioid-induced Constipation Market Forecast
10.3.3 Korea Opioid-induced Constipation Market Forecast
10.3.4 Southeast Asia Opioid-induced Constipation Market Forecast
10.3.5 India Opioid-induced Constipation Market Forecast
10.3.6 Australia Opioid-induced Constipation Market Forecast
10.4 Europe Opioid-induced Constipation Forecast by Country (2023-2028)
10.4.1 Germany Opioid-induced Constipation Market Forecast
10.4.2 France Opioid-induced Constipation Market Forecast
10.4.3 UK Opioid-induced Constipation Market Forecast
10.4.4 Italy Opioid-induced Constipation Market Forecast
10.4.5 Russia Opioid-induced Constipation Market Forecast
10.5 Middle East & Africa Opioid-induced Constipation Forecast by Region (2023-2028)
10.5.1 Egypt Opioid-induced Constipation Market Forecast
10.5.2 South Africa Opioid-induced Constipation Market Forecast
10.5.3 Israel Opioid-induced Constipation Market Forecast
10.5.4 Turkey Opioid-induced Constipation Market Forecast
10.5.5 GCC Countries Opioid-induced Constipation Market Forecast
10.6 Global Opioid-induced Constipation Forecast by Type (2023-2028)
10.7 Global Opioid-induced Constipation Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Opioid-induced Constipation Product Offered
11.1.3 AstraZeneca Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Information
11.2.2 Takeda Pharmaceutical Opioid-induced Constipation Product Offered
11.2.3 Takeda Pharmaceutical Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Takeda Pharmaceutical Main Business Overview
11.2.5 Takeda Pharmaceutical Latest Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Information
11.3.2 Bausch Health Opioid-induced Constipation Product Offered
11.3.3 Bausch Health Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bausch Health Main Business Overview
11.3.5 Bausch Health Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Opioid-induced Constipation Product Offered
11.4.3 Abbott Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Opioid-induced Constipation Product Offered
11.5.3 Bayer Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Opioid-induced Constipation Product Offered
11.6.3 Boehringer Ingelheim Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 C.B. Fleet
11.7.1 C.B. Fleet Company Information
11.7.2 C.B. Fleet Opioid-induced Constipation Product Offered
11.7.3 C.B. Fleet Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 C.B. Fleet Main Business Overview
11.7.5 C.B. Fleet Latest Developments
11.8 Cosmo Pharmaceuticals
11.8.1 Cosmo Pharmaceuticals Company Information
11.8.2 Cosmo Pharmaceuticals Opioid-induced Constipation Product Offered
11.8.3 Cosmo Pharmaceuticals Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Cosmo Pharmaceuticals Main Business Overview
11.8.5 Cosmo Pharmaceuticals Latest Developments
11.9 Daewoong
11.9.1 Daewoong Company Information
11.9.2 Daewoong Opioid-induced Constipation Product Offered
11.9.3 Daewoong Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Daewoong Main Business Overview
11.9.5 Daewoong Latest Developments
11.10 Daiichi Sankyo
11.10.1 Daiichi Sankyo Company Information
11.10.2 Daiichi Sankyo Opioid-induced Constipation Product Offered
11.10.3 Daiichi Sankyo Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Daiichi Sankyo Main Business Overview
11.10.5 Daiichi Sankyo Latest Developments
11. GLAXOSMITHKLINE
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Opioid-induced Constipation Product Offered
11.11.3 GlaxoSmithKline Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 GlaxoSmithKline Main Business Overview
11.11.5 GlaxoSmithKline Latest Developments
11.12 Ironwood Pharmaceuticals
11.12.1 Ironwood Pharmaceuticals Company Information
11.12.2 Ironwood Pharmaceuticals Opioid-induced Constipation Product Offered
11.12.3 Ironwood Pharmaceuticals Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Ironwood Pharmaceuticals Main Business Overview
11.12.5 Ironwood Pharmaceuticals Latest Developments
11.13 Johnson and Johnson
11.13.1 Johnson and Johnson Company Information
11.13.2 Johnson and Johnson Opioid-induced Constipation Product Offered
11.13.3 Johnson and Johnson Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Johnson and Johnson Main Business Overview
11.13.5 Johnson and Johnson Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Opioid-induced Constipation Product Offered
11.14.3 Merck Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Mundipharma
11.15.1 Mundipharma Company Information
11.15.2 Mundipharma Opioid-induced Constipation Product Offered
11.15.3 Mundipharma Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Mundipharma Main Business Overview
11.15.5 Mundipharma Latest Developments
11.16 Nektar Therapeutics
11.16.1 Nektar Therapeutics Company Information
11.16.2 Nektar Therapeutics Opioid-induced Constipation Product Offered
11.16.3 Nektar Therapeutics Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Nektar Therapeutics Main Business Overview
11.16.5 Nektar Therapeutics Latest Developments
11.17 Pfizer
11.17.1 Pfizer Company Information
11.17.2 Pfizer Opioid-induced Constipation Product Offered
11.17.3 Pfizer Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Pfizer Main Business Overview
11.17.5 Pfizer Latest Developments
11.18 Progenics Pharmaceuticals
11.18.1 Progenics Pharmaceuticals Company Information
11.18.2 Progenics Pharmaceuticals Opioid-induced Constipation Product Offered
11.18.3 Progenics Pharmaceuticals Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Progenics Pharmaceuticals Main Business Overview
11.18.5 Progenics Pharmaceuticals Latest Developments
11.19 Shionogi
11.19.1 Shionogi Company Information
11.19.2 Shionogi Opioid-induced Constipation Product Offered
11.19.3 Shionogi Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Shionogi Main Business Overview
11.19.5 Shionogi Latest Developments
11.20 SLA Pharma
11.20.1 SLA Pharma Company Information
11.20.2 SLA Pharma Opioid-induced Constipation Product Offered
11.20.3 SLA Pharma Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 SLA Pharma Main Business Overview
11.20.5 SLA Pharma Latest Developments
11.21 Sucampo
11.21.1 Sucampo Company Information
11.21.2 Sucampo Opioid-induced Constipation Product Offered
11.21.3 Sucampo Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Sucampo Main Business Overview
11.21.5 Sucampo Latest Developments
11.22 Synergy Pharmaceuticals
11.22.1 Synergy Pharmaceuticals Company Information
11.22.2 Synergy Pharmaceuticals Opioid-induced Constipation Product Offered
11.22.3 Synergy Pharmaceuticals Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Synergy Pharmaceuticals Main Business Overview
11.22.5 Synergy Pharmaceuticals Latest Developments
11.23 Theravance
11.23.1 Theravance Company Information
11.23.2 Theravance Opioid-induced Constipation Product Offered
11.23.3 Theravance Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Theravance Main Business Overview
11.23.5 Theravance Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid-induced Constipation Market Size 2017-2028
2.1.2 Opioid-induced Constipation Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Opioid-induced Constipation Segment by Type
2.2.1 Solid
2.2.2 Liquid
2.3 Opioid-induced Constipation Market Size by Type
2.3.1 Opioid-induced Constipation Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
2.4 Opioid-induced Constipation Segment by Application
2.4.1 Drugstore
2.4.2 Hospital
2.4.3 Others
2.5 Opioid-induced Constipation Market Size by Application
2.5.1 Opioid-induced Constipation Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
3 OPIOID-INDUCED CONSTIPATION MARKET SIZE BY PLAYER
3.1 Opioid-induced Constipation Market Size Market Share by Players
3.1.1 Global Opioid-induced Constipation Revenue by Players (2020-2022)
3.1.2 Global Opioid-induced Constipation Revenue Market Share by Players (2020-2022)
3.2 Global Opioid-induced Constipation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OPIOID-INDUCED CONSTIPATION BY REGIONS
4.1 Opioid-induced Constipation Market Size by Regions (2017-2022)
4.2 Americas Opioid-induced Constipation Market Size Growth (2017-2022)
4.3 APAC Opioid-induced Constipation Market Size Growth (2017-2022)
4.4 Europe Opioid-induced Constipation Market Size Growth (2017-2022)
4.5 Middle East & Africa Opioid-induced Constipation Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Opioid-induced Constipation Market Size by Country (2017-2022)
5.2 Americas Opioid-induced Constipation Market Size by Type (2017-2022)
5.3 Americas Opioid-induced Constipation Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid-induced Constipation Market Size by Region (2017-2022)
6.2 APAC Opioid-induced Constipation Market Size by Type (2017-2022)
6.3 APAC Opioid-induced Constipation Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Opioid-induced Constipation by Country (2017-2022)
7.2 Europe Opioid-induced Constipation Market Size by Type (2017-2022)
7.3 Europe Opioid-induced Constipation Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid-induced Constipation by Region (2017-2022)
8.2 Middle East & Africa Opioid-induced Constipation Market Size by Type (2017-2022)
8.3 Middle East & Africa Opioid-induced Constipation Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET FORECAST
10.1 Global Opioid-induced Constipation Forecast by Regions (2023-2028)
10.1.1 Global Opioid-induced Constipation Forecast by Regions (2023-2028)
10.1.2 Americas Opioid-induced Constipation Forecast
10.1.3 APAC Opioid-induced Constipation Forecast
10.1.4 Europe Opioid-induced Constipation Forecast
10.1.5 Middle East & Africa Opioid-induced Constipation Forecast
10.2 Americas Opioid-induced Constipation Forecast by Country (2023-2028)
10.2.1 United States Opioid-induced Constipation Market Forecast
10.2.2 Canada Opioid-induced Constipation Market Forecast
10.2.3 Mexico Opioid-induced Constipation Market Forecast
10.2.4 Brazil Opioid-induced Constipation Market Forecast
10.3 APAC Opioid-induced Constipation Forecast by Region (2023-2028)
10.3.1 China Opioid-induced Constipation Market Forecast
10.3.2 Japan Opioid-induced Constipation Market Forecast
10.3.3 Korea Opioid-induced Constipation Market Forecast
10.3.4 Southeast Asia Opioid-induced Constipation Market Forecast
10.3.5 India Opioid-induced Constipation Market Forecast
10.3.6 Australia Opioid-induced Constipation Market Forecast
10.4 Europe Opioid-induced Constipation Forecast by Country (2023-2028)
10.4.1 Germany Opioid-induced Constipation Market Forecast
10.4.2 France Opioid-induced Constipation Market Forecast
10.4.3 UK Opioid-induced Constipation Market Forecast
10.4.4 Italy Opioid-induced Constipation Market Forecast
10.4.5 Russia Opioid-induced Constipation Market Forecast
10.5 Middle East & Africa Opioid-induced Constipation Forecast by Region (2023-2028)
10.5.1 Egypt Opioid-induced Constipation Market Forecast
10.5.2 South Africa Opioid-induced Constipation Market Forecast
10.5.3 Israel Opioid-induced Constipation Market Forecast
10.5.4 Turkey Opioid-induced Constipation Market Forecast
10.5.5 GCC Countries Opioid-induced Constipation Market Forecast
10.6 Global Opioid-induced Constipation Forecast by Type (2023-2028)
10.7 Global Opioid-induced Constipation Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Opioid-induced Constipation Product Offered
11.1.3 AstraZeneca Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Information
11.2.2 Takeda Pharmaceutical Opioid-induced Constipation Product Offered
11.2.3 Takeda Pharmaceutical Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Takeda Pharmaceutical Main Business Overview
11.2.5 Takeda Pharmaceutical Latest Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Information
11.3.2 Bausch Health Opioid-induced Constipation Product Offered
11.3.3 Bausch Health Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bausch Health Main Business Overview
11.3.5 Bausch Health Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Opioid-induced Constipation Product Offered
11.4.3 Abbott Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Opioid-induced Constipation Product Offered
11.5.3 Bayer Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Opioid-induced Constipation Product Offered
11.6.3 Boehringer Ingelheim Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 C.B. Fleet
11.7.1 C.B. Fleet Company Information
11.7.2 C.B. Fleet Opioid-induced Constipation Product Offered
11.7.3 C.B. Fleet Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 C.B. Fleet Main Business Overview
11.7.5 C.B. Fleet Latest Developments
11.8 Cosmo Pharmaceuticals
11.8.1 Cosmo Pharmaceuticals Company Information
11.8.2 Cosmo Pharmaceuticals Opioid-induced Constipation Product Offered
11.8.3 Cosmo Pharmaceuticals Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Cosmo Pharmaceuticals Main Business Overview
11.8.5 Cosmo Pharmaceuticals Latest Developments
11.9 Daewoong
11.9.1 Daewoong Company Information
11.9.2 Daewoong Opioid-induced Constipation Product Offered
11.9.3 Daewoong Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Daewoong Main Business Overview
11.9.5 Daewoong Latest Developments
11.10 Daiichi Sankyo
11.10.1 Daiichi Sankyo Company Information
11.10.2 Daiichi Sankyo Opioid-induced Constipation Product Offered
11.10.3 Daiichi Sankyo Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Daiichi Sankyo Main Business Overview
11.10.5 Daiichi Sankyo Latest Developments
11. GLAXOSMITHKLINE
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Opioid-induced Constipation Product Offered
11.11.3 GlaxoSmithKline Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 GlaxoSmithKline Main Business Overview
11.11.5 GlaxoSmithKline Latest Developments
11.12 Ironwood Pharmaceuticals
11.12.1 Ironwood Pharmaceuticals Company Information
11.12.2 Ironwood Pharmaceuticals Opioid-induced Constipation Product Offered
11.12.3 Ironwood Pharmaceuticals Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Ironwood Pharmaceuticals Main Business Overview
11.12.5 Ironwood Pharmaceuticals Latest Developments
11.13 Johnson and Johnson
11.13.1 Johnson and Johnson Company Information
11.13.2 Johnson and Johnson Opioid-induced Constipation Product Offered
11.13.3 Johnson and Johnson Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Johnson and Johnson Main Business Overview
11.13.5 Johnson and Johnson Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Opioid-induced Constipation Product Offered
11.14.3 Merck Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Mundipharma
11.15.1 Mundipharma Company Information
11.15.2 Mundipharma Opioid-induced Constipation Product Offered
11.15.3 Mundipharma Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Mundipharma Main Business Overview
11.15.5 Mundipharma Latest Developments
11.16 Nektar Therapeutics
11.16.1 Nektar Therapeutics Company Information
11.16.2 Nektar Therapeutics Opioid-induced Constipation Product Offered
11.16.3 Nektar Therapeutics Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Nektar Therapeutics Main Business Overview
11.16.5 Nektar Therapeutics Latest Developments
11.17 Pfizer
11.17.1 Pfizer Company Information
11.17.2 Pfizer Opioid-induced Constipation Product Offered
11.17.3 Pfizer Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Pfizer Main Business Overview
11.17.5 Pfizer Latest Developments
11.18 Progenics Pharmaceuticals
11.18.1 Progenics Pharmaceuticals Company Information
11.18.2 Progenics Pharmaceuticals Opioid-induced Constipation Product Offered
11.18.3 Progenics Pharmaceuticals Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Progenics Pharmaceuticals Main Business Overview
11.18.5 Progenics Pharmaceuticals Latest Developments
11.19 Shionogi
11.19.1 Shionogi Company Information
11.19.2 Shionogi Opioid-induced Constipation Product Offered
11.19.3 Shionogi Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Shionogi Main Business Overview
11.19.5 Shionogi Latest Developments
11.20 SLA Pharma
11.20.1 SLA Pharma Company Information
11.20.2 SLA Pharma Opioid-induced Constipation Product Offered
11.20.3 SLA Pharma Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 SLA Pharma Main Business Overview
11.20.5 SLA Pharma Latest Developments
11.21 Sucampo
11.21.1 Sucampo Company Information
11.21.2 Sucampo Opioid-induced Constipation Product Offered
11.21.3 Sucampo Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Sucampo Main Business Overview
11.21.5 Sucampo Latest Developments
11.22 Synergy Pharmaceuticals
11.22.1 Synergy Pharmaceuticals Company Information
11.22.2 Synergy Pharmaceuticals Opioid-induced Constipation Product Offered
11.22.3 Synergy Pharmaceuticals Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Synergy Pharmaceuticals Main Business Overview
11.22.5 Synergy Pharmaceuticals Latest Developments
11.23 Theravance
11.23.1 Theravance Company Information
11.23.2 Theravance Opioid-induced Constipation Product Offered
11.23.3 Theravance Opioid-induced Constipation Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Theravance Main Business Overview
11.23.5 Theravance Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioid-induced Constipation Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Solid
Table 3. Major Players of Liquid
Table 4. Opioid-induced Constipation Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 7. Opioid-induced Constipation Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 10. Global Opioid-induced Constipation Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Opioid-induced Constipation Revenue Market Share by Player (2020-2022)
Table 12. Opioid-induced Constipation Key Players Head office and Products Offered
Table 13. Opioid-induced Constipation Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Opioid-induced Constipation Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Opioid-induced Constipation Market Size Market Share by Regions (2017-2022)
Table 18. Americas Opioid-induced Constipation Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Opioid-induced Constipation Market Size Market Share by Country (2017-2022)
Table 20. Americas Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 22. Americas Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 24. APAC Opioid-induced Constipation Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Opioid-induced Constipation Market Size Market Share by Region (2017-2022)
Table 26. APAC Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 28. APAC Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 30. Europe Opioid-induced Constipation Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Opioid-induced Constipation Market Size Market Share by Country (2017-2022)
Table 32. Europe Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 34. Europe Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Opioid-induced Constipation Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Opioid-induced Constipation
Table 43. Key Market Challenges & Risks of Opioid-induced Constipation
Table 44. Key Industry Trends of Opioid-induced Constipation
Table 45. Global Opioid-induced Constipation Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Opioid-induced Constipation Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Opioid-induced Constipation Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Opioid-induced Constipation Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Opioid-induced Constipation Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Opioid-induced Constipation Market Size Market Share Forecast by Application (2023-2028)
Table 51. AstraZeneca Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 52. AstraZeneca Opioid-induced Constipation Product Offered
Table 53. AstraZeneca Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Takeda Pharmaceutical Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 57. Takeda Pharmaceutical Opioid-induced Constipation Product Offered
Table 58. Takeda Pharmaceutical Main Business
Table 59. Takeda Pharmaceutical Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Takeda Pharmaceutical Latest Developments
Table 61. Bausch Health Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 62. Bausch Health Opioid-induced Constipation Product Offered
Table 63. Bausch Health Main Business
Table 64. Bausch Health Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bausch Health Latest Developments
Table 66. Abbott Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 67. Abbott Opioid-induced Constipation Product Offered
Table 68. Abbott Main Business
Table 69. Abbott Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Abbott Latest Developments
Table 71. Bayer Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 72. Bayer Opioid-induced Constipation Product Offered
Table 73. Bayer Main Business
Table 74. Bayer Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Bayer Latest Developments
Table 76. Boehringer Ingelheim Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 77. Boehringer Ingelheim Opioid-induced Constipation Product Offered
Table 78. Boehringer Ingelheim Main Business
Table 79. Boehringer Ingelheim Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Boehringer Ingelheim Latest Developments
Table 81. C.B. Fleet Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 82. C.B. Fleet Opioid-induced Constipation Product Offered
Table 83. C.B. Fleet Main Business
Table 84. C.B. Fleet Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. C.B. Fleet Latest Developments
Table 86. Cosmo Pharmaceuticals Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 87. Cosmo Pharmaceuticals Opioid-induced Constipation Product Offered
Table 88. Cosmo Pharmaceuticals Main Business
Table 89. Cosmo Pharmaceuticals Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Cosmo Pharmaceuticals Latest Developments
Table 91. Daewoong Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 92. Daewoong Opioid-induced Constipation Product Offered
Table 93. Daewoong Main Business
Table 94. Daewoong Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Daewoong Latest Developments
Table 96. Daiichi Sankyo Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 97. Daiichi Sankyo Opioid-induced Constipation Product Offered
Table 98. Daiichi Sankyo Main Business
Table 99. Daiichi Sankyo Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Daiichi Sankyo Latest Developments
Table 101. GlaxoSmithKline Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 102. GlaxoSmithKline Opioid-induced Constipation Product Offered
Table 103. GlaxoSmithKline Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. GlaxoSmithKline Main Business
Table 105. GlaxoSmithKline Latest Developments
Table 106. Ironwood Pharmaceuticals Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 107. Ironwood Pharmaceuticals Opioid-induced Constipation Product Offered
Table 108. Ironwood Pharmaceuticals Main Business
Table 109. Ironwood Pharmaceuticals Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Ironwood Pharmaceuticals Latest Developments
Table 111. Johnson and Johnson Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 112. Johnson and Johnson Opioid-induced Constipation Product Offered
Table 113. Johnson and Johnson Main Business
Table 114. Johnson and Johnson Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Johnson and Johnson Latest Developments
Table 116. Merck Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 117. Merck Opioid-induced Constipation Product Offered
Table 118. Merck Main Business
Table 119. Merck Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Merck Latest Developments
Table 121. Mundipharma Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 122. Mundipharma Opioid-induced Constipation Product Offered
Table 123. Mundipharma Main Business
Table 124. Mundipharma Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Mundipharma Latest Developments
Table 126. Nektar Therapeutics Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 127. Nektar Therapeutics Opioid-induced Constipation Product Offered
Table 128. Nektar Therapeutics Main Business
Table 129. Nektar Therapeutics Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Nektar Therapeutics Latest Developments
Table 131. Pfizer Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 132. Pfizer Opioid-induced Constipation Product Offered
Table 133. Pfizer Main Business
Table 134. Pfizer Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Pfizer Latest Developments
Table 136. Progenics Pharmaceuticals Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 137. Progenics Pharmaceuticals Opioid-induced Constipation Product Offered
Table 138. Progenics Pharmaceuticals Main Business
Table 139. Progenics Pharmaceuticals Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Progenics Pharmaceuticals Latest Developments
Table 141. Shionogi Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 142. Shionogi Opioid-induced Constipation Product Offered
Table 143. Shionogi Main Business
Table 144. Shionogi Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Shionogi Latest Developments
Table 146. SLA Pharma Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 147. SLA Pharma Opioid-induced Constipation Product Offered
Table 148. SLA Pharma Main Business
Table 149. SLA Pharma Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. SLA Pharma Latest Developments
Table 151. Sucampo Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 152. Sucampo Opioid-induced Constipation Product Offered
Table 153. Sucampo Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Sucampo Main Business
Table 155. Sucampo Latest Developments
Table 156. Synergy Pharmaceuticals Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 157. Synergy Pharmaceuticals Opioid-induced Constipation Product Offered
Table 158. Synergy Pharmaceuticals Main Business
Table 159. Synergy Pharmaceuticals Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. Synergy Pharmaceuticals Latest Developments
Table 161. Theravance Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 162. Theravance Opioid-induced Constipation Product Offered
Table 163. Theravance Main Business
Table 164. Theravance Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 165. Theravance Latest Developments
Table 1. Opioid-induced Constipation Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Solid
Table 3. Major Players of Liquid
Table 4. Opioid-induced Constipation Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 7. Opioid-induced Constipation Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 10. Global Opioid-induced Constipation Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Opioid-induced Constipation Revenue Market Share by Player (2020-2022)
Table 12. Opioid-induced Constipation Key Players Head office and Products Offered
Table 13. Opioid-induced Constipation Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Opioid-induced Constipation Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Opioid-induced Constipation Market Size Market Share by Regions (2017-2022)
Table 18. Americas Opioid-induced Constipation Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Opioid-induced Constipation Market Size Market Share by Country (2017-2022)
Table 20. Americas Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 22. Americas Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 24. APAC Opioid-induced Constipation Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Opioid-induced Constipation Market Size Market Share by Region (2017-2022)
Table 26. APAC Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 28. APAC Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 30. Europe Opioid-induced Constipation Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Opioid-induced Constipation Market Size Market Share by Country (2017-2022)
Table 32. Europe Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 34. Europe Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Opioid-induced Constipation Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Opioid-induced Constipation Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Opioid-induced Constipation Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Opioid-induced Constipation
Table 43. Key Market Challenges & Risks of Opioid-induced Constipation
Table 44. Key Industry Trends of Opioid-induced Constipation
Table 45. Global Opioid-induced Constipation Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Opioid-induced Constipation Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Opioid-induced Constipation Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Opioid-induced Constipation Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Opioid-induced Constipation Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Opioid-induced Constipation Market Size Market Share Forecast by Application (2023-2028)
Table 51. AstraZeneca Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 52. AstraZeneca Opioid-induced Constipation Product Offered
Table 53. AstraZeneca Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Takeda Pharmaceutical Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 57. Takeda Pharmaceutical Opioid-induced Constipation Product Offered
Table 58. Takeda Pharmaceutical Main Business
Table 59. Takeda Pharmaceutical Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Takeda Pharmaceutical Latest Developments
Table 61. Bausch Health Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 62. Bausch Health Opioid-induced Constipation Product Offered
Table 63. Bausch Health Main Business
Table 64. Bausch Health Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bausch Health Latest Developments
Table 66. Abbott Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 67. Abbott Opioid-induced Constipation Product Offered
Table 68. Abbott Main Business
Table 69. Abbott Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Abbott Latest Developments
Table 71. Bayer Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 72. Bayer Opioid-induced Constipation Product Offered
Table 73. Bayer Main Business
Table 74. Bayer Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Bayer Latest Developments
Table 76. Boehringer Ingelheim Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 77. Boehringer Ingelheim Opioid-induced Constipation Product Offered
Table 78. Boehringer Ingelheim Main Business
Table 79. Boehringer Ingelheim Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Boehringer Ingelheim Latest Developments
Table 81. C.B. Fleet Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 82. C.B. Fleet Opioid-induced Constipation Product Offered
Table 83. C.B. Fleet Main Business
Table 84. C.B. Fleet Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. C.B. Fleet Latest Developments
Table 86. Cosmo Pharmaceuticals Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 87. Cosmo Pharmaceuticals Opioid-induced Constipation Product Offered
Table 88. Cosmo Pharmaceuticals Main Business
Table 89. Cosmo Pharmaceuticals Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Cosmo Pharmaceuticals Latest Developments
Table 91. Daewoong Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 92. Daewoong Opioid-induced Constipation Product Offered
Table 93. Daewoong Main Business
Table 94. Daewoong Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Daewoong Latest Developments
Table 96. Daiichi Sankyo Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 97. Daiichi Sankyo Opioid-induced Constipation Product Offered
Table 98. Daiichi Sankyo Main Business
Table 99. Daiichi Sankyo Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Daiichi Sankyo Latest Developments
Table 101. GlaxoSmithKline Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 102. GlaxoSmithKline Opioid-induced Constipation Product Offered
Table 103. GlaxoSmithKline Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. GlaxoSmithKline Main Business
Table 105. GlaxoSmithKline Latest Developments
Table 106. Ironwood Pharmaceuticals Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 107. Ironwood Pharmaceuticals Opioid-induced Constipation Product Offered
Table 108. Ironwood Pharmaceuticals Main Business
Table 109. Ironwood Pharmaceuticals Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Ironwood Pharmaceuticals Latest Developments
Table 111. Johnson and Johnson Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 112. Johnson and Johnson Opioid-induced Constipation Product Offered
Table 113. Johnson and Johnson Main Business
Table 114. Johnson and Johnson Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Johnson and Johnson Latest Developments
Table 116. Merck Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 117. Merck Opioid-induced Constipation Product Offered
Table 118. Merck Main Business
Table 119. Merck Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Merck Latest Developments
Table 121. Mundipharma Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 122. Mundipharma Opioid-induced Constipation Product Offered
Table 123. Mundipharma Main Business
Table 124. Mundipharma Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Mundipharma Latest Developments
Table 126. Nektar Therapeutics Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 127. Nektar Therapeutics Opioid-induced Constipation Product Offered
Table 128. Nektar Therapeutics Main Business
Table 129. Nektar Therapeutics Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Nektar Therapeutics Latest Developments
Table 131. Pfizer Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 132. Pfizer Opioid-induced Constipation Product Offered
Table 133. Pfizer Main Business
Table 134. Pfizer Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Pfizer Latest Developments
Table 136. Progenics Pharmaceuticals Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 137. Progenics Pharmaceuticals Opioid-induced Constipation Product Offered
Table 138. Progenics Pharmaceuticals Main Business
Table 139. Progenics Pharmaceuticals Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Progenics Pharmaceuticals Latest Developments
Table 141. Shionogi Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 142. Shionogi Opioid-induced Constipation Product Offered
Table 143. Shionogi Main Business
Table 144. Shionogi Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Shionogi Latest Developments
Table 146. SLA Pharma Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 147. SLA Pharma Opioid-induced Constipation Product Offered
Table 148. SLA Pharma Main Business
Table 149. SLA Pharma Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. SLA Pharma Latest Developments
Table 151. Sucampo Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 152. Sucampo Opioid-induced Constipation Product Offered
Table 153. Sucampo Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Sucampo Main Business
Table 155. Sucampo Latest Developments
Table 156. Synergy Pharmaceuticals Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 157. Synergy Pharmaceuticals Opioid-induced Constipation Product Offered
Table 158. Synergy Pharmaceuticals Main Business
Table 159. Synergy Pharmaceuticals Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. Synergy Pharmaceuticals Latest Developments
Table 161. Theravance Details, Company Type, Opioid-induced Constipation Area Served and Its Competitors
Table 162. Theravance Opioid-induced Constipation Product Offered
Table 163. Theravance Main Business
Table 164. Theravance Opioid-induced Constipation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 165. Theravance Latest Developments
LIST OF FIGURES
Figure 1. Opioid-induced Constipation Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Opioid-induced Constipation Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Opioid-induced Constipation Market Size Market Share by Type in 2021
Figure 7. Opioid-induced Constipation in Drugstore
Figure 8. Global Opioid-induced Constipation Market: Drugstore (2017-2022) & ($ Millions)
Figure 9. Opioid-induced Constipation in Hospital
Figure 10. Global Opioid-induced Constipation Market: Hospital (2017-2022) & ($ Millions)
Figure 11. Opioid-induced Constipation in Others
Figure 12. Global Opioid-induced Constipation Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 14. Global Opioid-induced Constipation Revenue Market Share by Player in 2021
Figure 15. Global Opioid-induced Constipation Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Opioid-induced Constipation Market Size 2017-2022 ($ Millions)
Figure 17. APAC Opioid-induced Constipation Market Size 2017-2022 ($ Millions)
Figure 18. Europe Opioid-induced Constipation Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Opioid-induced Constipation Market Size 2017-2022 ($ Millions)
Figure 20. Americas Opioid-induced Constipation Value Market Share by Country in 2021
Figure 21. Americas Opioid-induced Constipation Consumption Market Share by Type in 2021
Figure 22. Americas Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 23. United States Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Opioid-induced Constipation Market Size Market Share by Region in 2021
Figure 28. APAC Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 29. China Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Opioid-induced Constipation Market Size Market Share by Country in 2021
Figure 36. Europe Opioid-induced Constipation Market Size Market Share by Type in 2021
Figure 37. Europe Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 38. Germany Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 46. Egypt Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 52. APAC Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 53. Europe Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 55. United States Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 56. Canada Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 59. China Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 60. Japan Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 61. Korea Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 63. India Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 64. Australia Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 65. Germany Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 66. France Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 67. UK Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 68. Italy Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 69. Russia Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 70. Spain Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 73. Israel Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 1. Opioid-induced Constipation Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Opioid-induced Constipation Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Opioid-induced Constipation Market Size Market Share by Type in 2021
Figure 7. Opioid-induced Constipation in Drugstore
Figure 8. Global Opioid-induced Constipation Market: Drugstore (2017-2022) & ($ Millions)
Figure 9. Opioid-induced Constipation in Hospital
Figure 10. Global Opioid-induced Constipation Market: Hospital (2017-2022) & ($ Millions)
Figure 11. Opioid-induced Constipation in Others
Figure 12. Global Opioid-induced Constipation Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 14. Global Opioid-induced Constipation Revenue Market Share by Player in 2021
Figure 15. Global Opioid-induced Constipation Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Opioid-induced Constipation Market Size 2017-2022 ($ Millions)
Figure 17. APAC Opioid-induced Constipation Market Size 2017-2022 ($ Millions)
Figure 18. Europe Opioid-induced Constipation Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Opioid-induced Constipation Market Size 2017-2022 ($ Millions)
Figure 20. Americas Opioid-induced Constipation Value Market Share by Country in 2021
Figure 21. Americas Opioid-induced Constipation Consumption Market Share by Type in 2021
Figure 22. Americas Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 23. United States Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Opioid-induced Constipation Market Size Market Share by Region in 2021
Figure 28. APAC Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 29. China Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Opioid-induced Constipation Market Size Market Share by Country in 2021
Figure 36. Europe Opioid-induced Constipation Market Size Market Share by Type in 2021
Figure 37. Europe Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 38. Germany Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Opioid-induced Constipation Market Size Market Share by Application in 2021
Figure 46. Egypt Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Opioid-induced Constipation Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 52. APAC Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 53. Europe Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 55. United States Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 56. Canada Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 59. China Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 60. Japan Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 61. Korea Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 63. India Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 64. Australia Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 65. Germany Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 66. France Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 67. UK Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 68. Italy Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 69. Russia Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 70. Spain Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 73. Israel Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Opioid-induced Constipation Market Size 2023-2028 ($ Millions)
